Skip Navigation




Anti-Corruption Policy

Sysmex Group Global Compliance Code (Excerpt)
10. To Maintain Sound Relationships with Society

We shall comply with applicable laws and regulations related to anti-bribery statutes and comply strictly with applicable laws regarding making political donations. The company shall not be intimidated by antisocial activities, behavior and groups, nor maintain any relationship with them.

10-1 Prohibition of bribery and excessive entertainment

In giving or accepting entertainment or gifts, we shall limit such activities to the scope of socially accepted practices and comply with applicable anti-bribery and other laws and regulations.

10-2 Prohibition of inappropriate political donations

When making political donations to politicians or political bodies, all Officers/Employees shall comply with applicable laws and regulations. Further, no Officer/Employee may make a political donation in anticipation of any benefit or quid pro quo, including the acquisition or maintenance of a business opportunity or an opportunity to access unpublicized information.

Sysmex Promotion Code

Item “2. Promoting Fair Dealing and Free Competition” of the Sysmex Group Global Compliance Code sets forth our code of ethics for marketing as part of our global promotion activities. Furthermore, we have formulated the Sysmex Promotion Code, which establishes more detailed and specific guidelines for activities in Japan. In fiscal 2016, we established detailed core behaviors related to appropriate clinical research in line with voluntary industry standards.

Creating Regulations and Conducting Training on Bribery Prevention

Sysmex is striving to prevent corruption based on the 10th principle of the Global Compact, that "Businesses should work against corruption in all its forms, including extortion and bribery."

We have prepared a practical guide that covers applicable laws not only in Japan, but also in the United States, the United Kingdom, China and other major countries, and use this guide in universal awareness activities. The momentum of efforts to eradicate corruption is gathering pace throughout the world, and various countries are enacting laws and stepping up enforcement on the prevention of bribery. Against this backdrop, in April 2016 Sysmex formulated Global Anti-Bribery Regulations, which apply to all Group companies. In April 2017, we also formulated Group Anti-Bribery Regulations targeting Group companies in Japan. These regulations cover such topics as banned items, due diligence and management systems.

In fiscal 2016, we conducted education on bribery prevention targeting all Sysmex Group employees.

Transparency in Relationships with Medical Institutions


Sysmex, with its Group corporate mission of "Shaping the advancement of healthcare," conducts business activities with the aim of providing reassurance to its various stakeholders, including customers. As part of this objective, at every stage of our operations—from research and development to manufacturing, sales and after-sales support—we are increasing the number of opportunities for collaboration with medical institutions and medical professionals. We believe that maintaining a strong sense of ethics as we go about these activities is important in securing broader society’s understanding of us as a company.

Responses in Japan

In 2012, the Japan Association of Clinical Reagents Industries formulated guidelines for ensuring the transparency of relationships between corporate activities and medical institutions. Concurring with the spirit of these guidelines, Sysmex Corporation and Sysmex International Reagents disclose information about funding they provide to medical institutions.

Disclosure Method

We disclose relevant information on our website every fiscal year.

Target of Disclosure

This information is based on the "Guidelines on Transparency of Relationships between Corporate Activities and Medical Institutions" established by the Japan Association of Clinical Reagents Industries.

Responses in the US and France

Sunshine Acts have been enacted in the US and France. We report relevant payments or transfers of value to the US and French governments regularly.

Disclosure Method

We disclose relevant information on the US and French governments’ website every year*

*We also disclose it on our web site.

Target of Disclosure


Relevant payments or transfers of value to, or research with, the following recipients:
- Registered US physicians
- Teaching hospitals in the US


Relevant payments or transfers of value to, or agreements with, the following recipients:
- Physicians, medical professionals and medical students in France
- Health institutions (educational institutions or medical companies) in France

Back to "Compliance"